Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jan 4, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Taysha Gene Therapies, Inc.
| 1.18M |
—
|
—
| +101,255.38% | 1.19M |
Jan 2
| |||||||
Taysha Gene Therapies, Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 14
| |||||||
Taysha Gene Therapies, Inc.
| 444.44K |
$0.90 | $399,999.60 | +40.73% | 1.54M |
Aug 16
| |||||||
Ventas, Inc.
| 3.83K |
$45.63 | $174,991.05 | +27.85% | 17.6K |
May 16
| |||||||
Taysha Gene Therapies, Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 30
| |||||||
Taysha Gene Therapies, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 17
| |||||||
Ventas, Inc.
| 3.06K |
$57.25 | $174,956.00 | +28.53% | 13.77K |
Apr 27
| |||||||
Social Capital Suvretta Holdings Corp. I...
|
0
|
—
|
—
|
—
|
0
| ||||||||
Taysha Gene Therapies, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 17
| |||||||
Ventas, Inc.
| 3.16K |
—
|
—
| +41.80% | 10.71K |
May 25
| |||||||
Taysha Gene Therapies, Inc.
| 1.17K |
$22.35 | $26,149.50 |
∞
| 1.17K |
May 20
| |||||||
Taysha Gene Therapies, Inc.
| 1.09M |
—
|
—
|
∞
| 1.09M |
Sep 28
| |||||||
Taysha Gene Therapies, Inc.
|
0
|
—
|
—
|
—
|
0
|
Sep 23
| |||||||
Taysha Gene Therapies, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Ventas, Inc.
| 5.42K |
—
|
—
| +254.53% | 7.55K |
May 18
| |||||||
Neoleukin Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 5
| |||||||
Neoleukin Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Oct 10
| |||||||
Ventas, Inc.
| 2.13K |
$67.03 | $142,840.93 |
∞
| 2.13K |
Jul 26
| |||||||
Ventas, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Avexis, Inc.
| -11.00K |
—
|
—
| -100.00% |
0
|
May 15
| |||||||
Aquinox Pharmaceuticals, Inc
|
0
|
—
|
—
|
—
|
0
|
May 7
| |||||||
Avexis, Inc.
| 11K |
—
|
—
|
∞
| 11K |
Mar 13
| |||||||
Avexis, Inc.
|
0
|
$72.71 | -$1,135,257.00 |
—
|
0
|
Mar 7
|
Scheduled
| ||||||
Avexis, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 10
| |||||||
Aquinox Pharmaceuticals, Inc
|
0
|
—
|
—
|
—
|
0
|
May 8
| |||||||
Avexis, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 20
| |||||||
Aquinox Pharmaceuticals, Inc
|
0
|
—
|
—
|
—
|
0
|
May 9
| |||||||
Avexis, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Aquinox Pharmaceuticals, Inc
|
0
|
—
|
—
|
—
|
0
|
Mar 12
| |||||||
Aquinox Pharmaceuticals, Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Intermune Inc
| -65.67K |
$74.00 | -$4,859,654.00 | -100.00% |
0
|
Sep 29
| |||||||
Intermune Inc
|
0
|
$29.65 | -$692,070.00 |
—
| 65.67K |
Aug 13
|
Scheduled
| ||||||
Intermune Inc
|
0
|
$28.20 | -$378,100.00 |
—
| 65.67K |
Jun 18
|
Scheduled
| ||||||
Intermune Inc
|
0
|
$26.05 | -$670,200.00 |
—
| 65.67K |
Jun 6 - Jun 13
|
Scheduled
| ||||||
Intermune Inc
|
0
|
$26.05 | -$670,200.00 |
—
| 65.67K |
Jun 6 - Jun 13
|
Scheduled
| ||||||
Intermune Inc
| -385.00 |
$38.78 | -$14,930.18 | -0.58% | 65.67K |
Jun 3
| |||||||
Intermune Inc
| 1K |
—
|
—
| +1.54% | 66.06K |
May 29 - May 30
| |||||||
Intermune Inc
| -7.50K |
$39.50 | -$296,250.00 | -10.34% | 65.06K |
May 19
|
Scheduled
| ||||||
Intermune Inc
| -2.64K |
$35.85 | -$94,780.53 | -3.52% | 72.56K |
May 8
| |||||||
Intermune Inc
|
0
|
—
|
—
|
—
|
0
|
May 30
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. |
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.